To access this element change to forms mode OFF
Grant Award View - GA205215
Legumain at the cutting edge of oral cancer
GA ID:
GA205215
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
3-Nov-2021
Publish Date:
13-Dec-2021
Category:
Medical Research
Grant Term:
1-Jan-2022 to 1-Jan-2025
Value (AUD):
$588,593.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Ideas Grants
Grant Activity:
Legumain at the cutting edge of oral cancer
Purpose:
Oral cancer patients suffer from profound pain and the survival rate is low due to the spread of the cancer. Effective therapies to treat oral cancer pain and prevent its spread are currently lacking. We have identified an enzyme that promotes cancer pain, and drugs that block its activity are effective at relieving pain. We will test the contribution of this enzyme to cancer spread and determine whether drugs blocking its activity are effective at preventing spread and alleviating pain.
GO ID:
GO Title:
2021 Ideas Grants
Internal Reference ID:
2021/GNT2011119
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, VIC, Overseas
Postcode:
Multiple
Country:
AUSTRALIA, CANADA, UNITED STATES